Rani Therapeutics Holdings, Inc. ($RANI) is pioneering a bold approach to drug delivery—turning injectable biologics into oral pills with its “robotic capsule,” the RaniPill. In this episode, we explore the company’s innovative technology, its journey from concept to clinical-stage, and the challenges of translating engineering breakthroughs into approved medicines. With early human data, a growing pipeline, and a platform designed for scalability, Rani aims to redefine how complex drugs are taken. But with no approved products, heavy R&D spend, and the high bar of clinical, regulatory, and manufacturing hurdles, the question remains: can Rani turn promise into profit—or will biology prove tougher than engineering?
This podcast is for informational and educational purposes only. Information may not be complete or accurate. It does not constitute financial, investment, legal, or other professional advice. Always do your own research and consult with a licensed financial advisor.
